[{"address1": "1000 Skokie Boulevard", "address2": "Suite 350", "city": "Wilmette", "state": "IL", "zip": "60091", "country": "United States", "phone": "847 388 0349", "website": "https://www.monopartx.com", "industry": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Monopar Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics for the treatment of cancer in the United States. The company develops MNPR-101-Zr, a clinical stage urokinase plasminogen activator receptor-targeted radiodiagnostic imaging agent; and MNPR-101-RIT, a late preclinical stage radiotherapeutic for advanced cancers. It also develops Camsirubicin, a Phase 1b clinical stage novel analog of doxorubicin, which is in Phase 1b clinical trial for the treatment of advanced soft tissue sarcoma; and MNPR-202, an analog of Camsirubicin to treat doxorubicin-and camsirubicin-resistant cancers. Monopar Therapeutics Inc. has collaborations NorthStar to develop radio-immuno-therapeutics targeting severe COVID-19; and the Cancer Science Institute of Singapore to evaluate the activity of MNPR-202 and related analogs in various types of cancer. The company was founded in 2014 and is headquartered in Wilmette, Illinois. Monopar Therapeutics Inc. is a subsidiary of Tacticgem LLC.", "fullTimeEmployees": 9, "companyOfficers": [{"maxAge": 1, "name": "Dr. Christopher M. Starr Ph.D.", "age": 71, "title": "Co-Founder & Independent Executive Chairman of the Board", "yearBorn": 1952, "fiscalYear": 2023, "totalPay": 200000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Chandler D. Robinson M.B.A., M.D., M.Sc., MBA, MSc", "age": 39, "title": "Co-Founder, CEO, President & Director", "yearBorn": 1984, "fiscalYear": 2023, "totalPay": 710500, "exercisedValue": 0, "unexercisedValue": 56986}, {"maxAge": 1, "name": "Mr. Andrew J. Cittadine M.B.A.", "age": 51, "title": "Chief Operating Officer", "yearBorn": 1972, "fiscalYear": 2023, "totalPay": 416700, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Karthik  Radhakrishnan CFA", "age": 52, "title": "CFO, Principal Accounting Officer & Principal Financial Officer", "yearBorn": 1971, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Patrice P. Rioux M.D., Ph.D.", "age": 72, "title": "Acting Chief Medical Officer", "yearBorn": 1951, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 2, "previousClose": 4.41, "open": 4.32, "dayLow": 4.12, "dayHigh": 5.47, "regularMarketPreviousClose": 4.41, "regularMarketOpen": 4.32, "regularMarketDayLow": 4.12, "regularMarketDayHigh": 5.47, "beta": 1.162, "forwardPE": -3.1717792, "volume": 2279380, "regularMarketVolume": 2279380, "averageVolume": 773157, "averageVolume10days": 4534150, "averageDailyVolume10Day": 4534150, "bid": 5.04, "ask": 5.18, "bidSize": 100, "askSize": 100, "marketCap": 18200314, "fiftyTwoWeekLow": 1.37, "fiftyTwoWeekHigh": 8.65, "fiftyDayAverage": 3.0992, "twoHundredDayAverage": 3.12775, "currency": "USD", "enterpriseValue": 11081516, "floatShares": 1644327, "sharesOutstanding": 3520370, "sharesShort": 92795, "sharesShortPriorMonth": 17962, "sharesShortPreviousMonthDate": 1722384000, "dateShortInterest": 1724976000, "sharesPercentSharesOut": 0.026400002, "heldPercentInsiders": 0.53291, "heldPercentInstitutions": 0.023759998, "shortRatio": 0.74, "shortPercentOfFloat": 0.1902, "bookValue": 1.73, "priceToBook": 2.9884393, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "netIncomeToCommon": -7124184, "trailingEps": -2.3, "forwardEps": -1.63, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "MNPR", "underlyingSymbol": "MNPR", "shortName": "Monopar Therapeutics Inc.", "longName": "Monopar Therapeutics Inc.", "firstTradeDateEpochUtc": 1576765800, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "4c85e6c0-debc-355c-95b2-bf3324d36ecc", "gmtOffSetMilliseconds": -14400000, "currentPrice": 5.17, "targetHighPrice": 30.0, "targetLowPrice": 9.0, "targetMeanPrice": 18.0, "targetMedianPrice": 15.0, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 3, "totalCash": 7118771, "totalCashPerShare": 2.022, "quickRatio": 6.534, "currentRatio": 6.59, "returnOnAssets": -0.53445, "returnOnEquity": -1.02307, "freeCashflow": -4433461, "operatingCashflow": -6817933, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-09-26"}]